ZA982808B - Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia - Google Patents
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementiaInfo
- Publication number
- ZA982808B ZA982808B ZA982808A ZA982808A ZA982808B ZA 982808 B ZA982808 B ZA 982808B ZA 982808 A ZA982808 A ZA 982808A ZA 982808 A ZA982808 A ZA 982808A ZA 982808 B ZA982808 B ZA 982808B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyclooxygenase
- inhibitors
- dementia
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4391697P | 1997-04-03 | 1997-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA982808B true ZA982808B (en) | 1999-04-06 |
Family
ID=21929578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA982808A ZA982808B (en) | 1997-04-03 | 1998-04-02 | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0971714B1 (de) |
JP (1) | JP2002514208A (de) |
AT (1) | ATE225660T1 (de) |
AU (1) | AU725697B2 (de) |
BR (1) | BR9807920A (de) |
CA (1) | CA2285434A1 (de) |
DE (1) | DE69808607T2 (de) |
DK (1) | DK0971714T3 (de) |
ES (1) | ES2185154T3 (de) |
HK (1) | HK1024872A1 (de) |
PT (1) | PT971714E (de) |
WO (1) | WO1998043648A1 (de) |
ZA (1) | ZA982808B (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6727238B2 (en) | 1998-06-11 | 2004-04-27 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
US6294558B1 (en) | 1999-05-31 | 2001-09-25 | Pfizer Inc. | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9420616D0 (en) * | 1994-10-12 | 1994-11-30 | Merck Sharp & Dohme | Method, compositions and use |
CA2276945C (en) * | 1993-11-30 | 2006-08-01 | G.D. Searle & Co. | Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
US5486534A (en) * | 1994-07-21 | 1996-01-23 | G. D. Searle & Co. | 3,4-substituted pyrazoles for the treatment of inflammation |
US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
US5696143A (en) * | 1994-09-20 | 1997-12-09 | Talley; John J. | Benz G! indazolyl derivatives for the treatment of inflammation |
EP0828718A1 (de) * | 1995-06-02 | 1998-03-18 | G.D. SEARLE & CO. | Heterocyclo-substituierte hydroxaminsäurederivate als cyclooxygenase-2 und 5-lipoxygenase inhibitoren |
US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
US5700816A (en) * | 1995-06-12 | 1997-12-23 | Isakson; Peter C. | Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
CA2224563A1 (en) * | 1995-06-12 | 1996-12-27 | G.D. Searle & Co. | Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
DE69635048T2 (de) * | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
DE69739003D1 (de) * | 1996-04-12 | 2008-10-30 | Searle Llc | Substituierte Benzensulfonamid-Derivate als Wirkstoff-Vorläufer von COX-2 Inhibitoren |
-
1998
- 1998-03-30 ES ES98912108T patent/ES2185154T3/es not_active Expired - Lifetime
- 1998-03-30 PT PT98912108T patent/PT971714E/pt unknown
- 1998-03-30 DE DE69808607T patent/DE69808607T2/de not_active Expired - Fee Related
- 1998-03-30 CA CA002285434A patent/CA2285434A1/en not_active Abandoned
- 1998-03-30 BR BR9807920-4A patent/BR9807920A/pt not_active IP Right Cessation
- 1998-03-30 JP JP54186898A patent/JP2002514208A/ja not_active Ceased
- 1998-03-30 AU AU65904/98A patent/AU725697B2/en not_active Ceased
- 1998-03-30 DK DK98912108T patent/DK0971714T3/da active
- 1998-03-30 EP EP98912108A patent/EP0971714B1/de not_active Expired - Lifetime
- 1998-03-30 WO PCT/US1998/006143 patent/WO1998043648A1/en active IP Right Grant
- 1998-03-30 AT AT98912108T patent/ATE225660T1/de not_active IP Right Cessation
- 1998-04-02 ZA ZA982808A patent/ZA982808B/xx unknown
-
2000
- 2000-07-06 HK HK00104146A patent/HK1024872A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69808607T2 (de) | 2003-06-26 |
CA2285434A1 (en) | 1998-10-08 |
EP0971714B1 (de) | 2002-10-09 |
JP2002514208A (ja) | 2002-05-14 |
ATE225660T1 (de) | 2002-10-15 |
PT971714E (pt) | 2002-12-31 |
AU725697B2 (en) | 2000-10-19 |
DK0971714T3 (da) | 2002-11-04 |
WO1998043648A1 (en) | 1998-10-08 |
AU6590498A (en) | 1998-10-22 |
ES2185154T3 (es) | 2003-04-16 |
EP0971714A1 (de) | 2000-01-19 |
BR9807920A (pt) | 2000-02-22 |
DE69808607D1 (de) | 2002-11-14 |
HK1024872A1 (en) | 2000-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2267186A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia | |
WO1999005096A3 (en) | Urokinase inhibitors | |
UA35589C2 (uk) | ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ | |
HK1046403A1 (en) | Nematicidal trifluorobutenes. | |
MX9804623A (es) | Precursores inactivos de farmacos inhibidores de trombina. | |
WO2001005392A3 (en) | Method for treating chronic pain using mek inhibitors | |
EP0528858A4 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
CA2282654A1 (en) | Use of cholinesterase inhibitors to treat attention deficit hyperactivity disorder | |
ATE225351T1 (de) | Thienopyridin und thienopyrimidinderivate und ihre verwendung als entzündungshemmende mittel | |
MX9606744A (es) | Acidos hidroxamicos sustituidos por sulfonamido arilico como inhibidores de metaloproteinasa de matriz. | |
WO1994004541A3 (en) | Protein kinase inhibitors and related compounds combined with taxol | |
CA2257010A1 (en) | Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia | |
BG101110A (en) | Substituted pyrimidine compounds and their application | |
AP9901674A0 (en) | Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders. | |
CA2210258A1 (en) | Substituted oxazolidine calpain and/or cathepsin b inhibitors | |
WO1998036730A3 (de) | Zubereitungen für die behandlung von rosacea | |
NZ332096A (en) | Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition | |
CA2270469A1 (en) | Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents | |
WO2002005642A3 (en) | Synergistic biocidal compositions | |
CA2200126A1 (en) | Treatment and prophylaxis of pancreatitis | |
AU9066498A (en) | Substituted 6-alkylphenanthridines | |
GB2324091A (en) | Metalloproteinase inhibitors | |
MX9700624A (es) | Azolidinonas de imidazopiridina. | |
HK1024872A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia | |
CA2372912A1 (en) | Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |